Parallax Clinical Research, LLC is a consulting firm devoted to advancing the development of early stage pharmaceutical and biological products.   Parallax works closely with pharmaceutical and biotechnology companies to assist them in translating discoveries at the bench into viable clinical products through the following services:

·        Evaluate potential pipeline products

·        Create Clinical Development Plans

·        Design (synopsis and protocol) and conduct proof of pharmacology and proof of principle studies

·        Design (synopsis and protocol) and conduct all types of Phase I – Phase III clinical studies

·        Prepare Investigator Brochures, Clinical Study Reports and all types of Regulatory documentation

·        Medical Monitoring

In addition, Parallax works closely with venture capital groups performing due diligence to assess and evaluate new technologies and products through the following services:

·        Review the underlying science and educating venture capital staff

·        Evaluate the scientific validity of the proposed technology

·        Assess the competitive and regulatory landscape for the proposed technology

·        Evaluate the competency of the company to accomplish the proposed objectives